
- Top Workplaces
- SI-BONE
SI-BONE
Purpose
SI-BONE is a global leader in technology for surgical treatment of sacropelvic disorders. In 2009, SI-BONE pioneered a proprietary minimally invasive surgical system, the iFuse Implant System®, to fuse the SI joint and treat SI joint dysfunction. Tens of thousands of patients have subsequently been treated with iFuse by thousands of trained physicians around the world. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including two randomized controlled trials and over 135 peer-reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma. The expanded iFuse Technology® platform now includes iFuse 3D™, iFuse TORQ®, iFuse TORQ TNT™, and iFuse Bedrock Granite®.
SI-BONE is managed by an experienced team of executives from Kyphon, Medtronic, INBONE, Saint Francis and several start-up orthopedic and spine companies.
SI-BONE is managed by an experienced team of executives from Kyphon, Medtronic, INBONE, Saint Francis and several start-up orthopedic and spine companies.
Vision
Ambitiously growing and disrupting the spinopelvic market with innovative solutions supported by world-class evidence, education, advocacy, and clinical support.
Mission
Helping patients rise up and reach for the stars.
Additional Culture Details
SI-BONE is focused on helping patients in one of the most under-served, under-diagnosed, and under-treated areas in orthopedics, the sacroiliac (SI) joint. The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. The iFuse Implant System is also intended for sacroiliac fusion to augment immobilization and stabilization of the sacroiliac joint in skeletally mature patients undergoing sacropelvic fixation as a part of a lumbar or thoracolumbar fusion.
Values
- Core Value Statements
- We are purpose-driven in a tireless pursuit of our mission for patients. We learn and respond quickly to the needs of our stakeholders. We embrace creative solutions and challenge the status quo. We roll-up our sleeves and make things happen as one team.